期刊文献+

从缬沙坦结晶母液中回收缬沙坦

Recovery of Valsartan from Crystallization Mother Liquor of Valsartan
下载PDF
导出
摘要 通过酯化反应将缬沙坦结晶母液中含有的缬沙坦及其手性异构体制备成缬沙坦甲酯和缬沙坦甲酯异构体,利用结晶、过滤分离除去缬沙坦甲酯异构体,然后将滤液与氢氧化钠溶液混合,进行水解反应制备得到缬沙坦。 Valsartan and its chiral isomers contained in the mother liquor of valsartan crystallization were prepared into valsartan methyl ester and valsartan methyl ester isomers by esterification.Valsartan methyl ester isomers were separated by crystallization and filtration,and then the filtrate was mixed with sodium hydroxide solution to prepare valsartan by hydrolysis.
作者 张之建 Zhang Zhijian(Shanghai Pharma Group Changzhou Kony Pharmacuetical.Co.,Ltd.,Changzhou Jiangsu 213105)
出处 《山西化工》 2022年第2期28-30,共3页 Shanxi Chemical Industry
关键词 缬沙坦 母液 回收 Valsartan mother liquor recycle
  • 相关文献

参考文献2

二级参考文献21

  • 1Guidelines Subxommittee.1999 WorldHealth Organizatiou-International Society of Hypertension Guidelines for the Mana-gementof Hyertension. J Hypertersion.1999;17:151-183.
  • 2Weber MA.Clinical experience with the angiotensin Ⅱ receptor antagonistlosartan:a preliminary report. Am J Hypertens.1992;5:247S-251S.
  • 3De Gasparo M,Siragy HM.The AT2 recepor:fact,fancy and fantasy. RegulatoryPeptides.1999;81:11-24.
  • 4Criscone L,Gradley WA,Buehlmayerp,et al.Valsartan:preclinical and clinical profileof an antihypertensive angiotensin Ⅱ antagonist. Cardiovasc Drug Rev.1995;13:230-250.
  • 5Markham A,Goa KL.Valsartan.A review of its pharmacology and Therapeutic use inessential hypertension. Drugs.1997;54:299-311.
  • 6Griscione L,De Gasparo M,Buhlmayer P,et al.Pharmacological profile ofvalsartan:apotent,orally active,nonpeptide antagonist of the angiotensin Ⅱ AT1-receptorsubtype. Br J pharmacot.1993;110:761-771.
  • 7De Grasparo M,Whitebread S.Binding of valsartan to mammalian angiotensin AT1receptors. Regul Pept.1995;59:303-311.
  • 8Muller P,Flesch G,De Gasparo M et al.Pharmacokinetics and pharmacodynamic effect ofthe angiotensin Ⅱ antagonist valsartan at steady state in healthy,normotensive subjects.Eur J Clin Pharmacol.1997;52:441-449.
  • 9JR Benz,HR Black,A Graff et al.Valsartan and hydrochlorothiazide in patients withessential hypertension.A multiple dose,double-blind,placebo controlled trial comparingcombination therapy with monotherapy. J Human Hypertension.1998;12:861-866.
  • 10James pool,Suzanne Oparil,Thomas Hedner et al.Dose-Responsive AntihypertensiveEfficacy of valsartan,a New Angiotensin Ⅱ-Receptor Blocker. ClinicalTherapeutics.1998;20(6):1106-1114

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部